Literature DB >> 12849265

Vascular cognitive impairment.

John T O'Brien1, Timo Erkinjuntti, Barry Reisberg, Gustavo Roman, Tohru Sawada, Leonardo Pantoni, John V Bowler, Clive Ballard, Charles DeCarli, Philip B Gorelick, Kenneth Rockwood, Alistair Burns, Serge Gauthier, Steven T DeKosky.   

Abstract

Cerebrovascular disease is the second most common cause of acquired cognitive impairment and dementia and contributes to cognitive decline in the neurodegenerative dementias. The current narrow definitions of vascular dementia should be broadened to recognise the important part cerebrovascular disease plays in several cognitive disorders, including the hereditary vascular dementias, multi-infarct dementia, post-stroke dementia, subcortical ischaemic vascular disease and dementia, mild cognitive impairment, and degenerative dementias (including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies). Here we review the current state of scientific knowledge on the subject of vascular brain burden. Important non-cognitive features include depression, apathy, and psychosis. We propose use of the term vascular cognitive impairment, which is characterised by a specific cognitive profile involving preserved memory with impairments in attentional and executive functioning. Diagnostic criteria have been proposed for some subtypes of vascular cognitive impairment, and there is a pressing need to validate and further refine these. Clinical trials in vascular cognitive impairment are in their infancy but support the value of therapeutic interventions for symptomatic treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12849265     DOI: 10.1016/s1474-4422(03)00305-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  311 in total

1.  Dementia: poststroke dementia--an underestimated burden?

Authors:  Sandra Black
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

2.  Driving-Related Cognitive Performance in Older Adults with Pharmacologically Treated Cardiovascular Disease.

Authors:  Sarah Viamonte; David Vance; Virginia Wadley; Dan Roenker; Karlene Ball
Journal:  Clin Gerontol       Date:  2010-04-01       Impact factor: 2.619

3.  Early biomarkers for post-stroke cognitive impairment.

Authors:  Lai Qian; Lidong Ding; Liqun Cheng; Xiaolei Zhu; Hui Zhao; Jiali Jin; Dening Guan; Bing Zhang; Xuemei Chen; Yun Xu
Journal:  J Neurol       Date:  2012-03-10       Impact factor: 4.849

Review 4.  [Arterial hypertension and dementia].

Authors:  R Scheid; H Voigt
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

5.  Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease.

Authors:  Rebecca L Brookes; Kristin Hannesdottir; Robert Lawrence; Robin G Morris; Hugh S Markus
Journal:  Age Ageing       Date:  2012-01-19       Impact factor: 10.668

Review 6.  Cell-to-cell communication and vascular dementia.

Authors:  Hans H Dietrich
Journal:  Microcirculation       Date:  2012-07       Impact factor: 2.628

7.  Toward a pathological definition of vascular dementia.

Authors:  Lea Tenenholz Grinberg; Helmut Heinsen
Journal:  J Neurol Sci       Date:  2010-12-15       Impact factor: 3.181

8.  Ultra-Slow Single-Vessel BOLD and CBV-Based fMRI Spatiotemporal Dynamics and Their Correlation with Neuronal Intracellular Calcium Signals.

Authors:  Yi He; Maosen Wang; Xuming Chen; Rolf Pohmann; Jonathan R Polimeni; Klaus Scheffler; Bruce R Rosen; David Kleinfeld; Xin Yu
Journal:  Neuron       Date:  2018-02-21       Impact factor: 17.173

9.  Demographic and CT scan features related to cognitive impairment in the first year after stroke.

Authors:  S M C Rasquin; F R J Verhey; R J van Oostenbrugge; R Lousberg; J Lodder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

10.  White matter hyperintensities as a predictor of neuropsychological deficits post-stroke.

Authors:  H Jokinen; H Kalska; R Mäntylä; R Ylikoski; M Hietanen; T Pohjasvaara; M Kaste; T Erkinjuntti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.